Thu, March 21, 2024

Kalpit Patel Maintained (VRDN) at Strong Buy with Decreased Target to $25 on, Mar 21st, 2024

Kalpit Patel of B. Riley Securities, Maintained "Viridian Therapeutics, Inc." (VRDN) at Strong Buy with Decreased Target from $29 to $25 on, Mar 21st, 2024.

Kalpit has made no other calls on VRDN in the last 4 months.



There are 5 other peers that have a rating on VRDN. Out of the 5 peers that are also analyzing VRDN, 0 agree with Kalpit's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Kalpit


  • Serge Belanger of "Needham" Maintained at Strong Buy and Held Target at $30 on, Wednesday, March 20th, 2024
  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $37 on, Thursday, February 29th, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $40 on, Wednesday, February 28th, 2024
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $36 on, Tuesday, December 19th, 2023
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Thursday, December 14th, 2023